Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

CILOSTAZOL 100 MG TABLET

cilostazol
$0.1287per EA

Strength

100 mg/1

Manufacturer

Slate Run Pharmaceuticals LLC

NDC

70436015706

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

CILOSTAZOL

Approval Type

Generic (ANDA)

FDA Application

ANDA077208

On Market Since

1/1/2018

Pharmacological Classes

Phosphodiesterase 3 Inhibitor
Phosphodiesterase 3 Inhibitors

Price History

1W

0.0%

1M

-0.2%

3M

+1.5%

6M

+2.0%

1Y

-6.6%

3Y

-8.1%

5Y

N/A

All

-21.5%

Generic Alternatives

2 alternatives • Same active ingredient

CILOSTAZOL 100 MG TABLET
Generic
60505252201•Apotex Corp.
$0.1287
CILOSTAZOL 100 MG TABLET
Generic
50268017715•AvPAK
$0.1287

Related Drugs

Same classification

CILOSTAZOL 50 MG TABLET
Generic
00093206506•Teva Pharmaceuticals USA Inc.
$0.1162
per EA
CILOSTAZOL 100 MG TABLET
Generic
00093206406•Teva Pharmaceuticals USA Inc.
$0.1287
per EA
CILOSTAZOL 100 MG TABLET
Generic
00093206450•Teva Pharmaceuticals USA Inc.
$0.1287
per EA
ANAGRELIDE HCL 0.5 MG CAPSULE
Generic
13668045301•Torrent Pharmaceuticals Limited
$0.7265
per EA
ANAGRELIDE HCL 0.5 MG CAPSULE
Generic
62135031212•Chartwell RX LLC
$0.7265
per EA
ANAGRELIDE HCL 0.5 MG CAPSULE
Generic
70954087910•ANI Pharmaceuticals, Inc.
$0.7265
per EA
ANAGRELIDE HCL 1 MG CAPSULE
Generic
13668046201•Torrent Pharmaceuticals Limited
$1.5333
per EA
ANAGRELIDE HCL 1 MG CAPSULE
Generic
62135031360•Chartwell RX LLC
$1.5333
per EA
ANAGRELIDE HCL 1 MG CAPSULE
Generic
70954088110•ANI Pharmaceuticals, Inc.
$1.5333
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy